Stroke in the Very Elderly
To the Editor:
Atrial fibrillation (AF) is the most common, potent, and independent risk factor for ischemic stroke, 1 the incidence of which increases with age. 2 To determine the influence of advanced age on anticoagulation therapy in elderly patients with AF, a retrospective cohort study of all patients admitted in our department (from 1995 to 2003) was conducted. These patients were Ͼ90 years of age and had had an acute stroke. The following parameters were analyzed: age, sex, cardiovascular risk factors and their treatment, and outcome. Among the 404 patients experiencing acute stroke, 39 (9.65%) were Ͼ90 years old (average age 91.73Ϯ2.34), and 82% were females. Four patients had cognitive impairment (Alzheimer disease) whose quality of life was average for their age. Major risk factors for stroke were AF (64%), hypertension (51%), and diabetes mellitus (7%). Smoking habits, before stroke or transient ischemic attack (TIA), had not been found. None of the patients with AF had been treated with anticoagulant drugs except 4 who received acetylsalicylic acid. However, all patients with hypertension or diabetes were receiving drugs. All episodes of stroke were ischemic (hemispheric 28; TIA 8; and lacunar 3). Thirteen patients died (12 in the first 72 hours), all of them with AF. The death rate among the elderly patients was 33.3% and 10.35% in the remaining patients diagnosed with acute stroke over the same time period. Seven patients fully recovered previous health state and functions, whereas 19 did not. After discharge, 14 patients with no AF received antiplaquetary drugs. In the remaining with AF, 4 received warfarin, 2 received antiplaquetary drugs (because of the refusal of the family to receive anticoagulants), and no treatment was received by 6 patients, all of whom had an important cognitive impairment and disability after stroke. Incidence of stroke increases with the age, and 75% of strokes occur in the elderly. 3 AF is the most important single cause of ischemic stroke in this age group. 4 Several clinical trials have demonstrated that warfarin sodium treatment reduces risk of stroke and death compared with placebo in persons with AF. In addition, this benefit is accompanied by a relatively low annual bleeding rate. Unfortunately, these findings have not been adequately implemented in clinical practice. 1, 3, 5 Reduced odds of receiving warfarin is associated with the Ͼ85 age group, previous intracranial or gastrointestinal hemorrhage, or cognitive impairment. 1 However, pharmacological treatment for risk factors such as hypertension, diabetes, heart failure, and dyslipemia are currently applied. Stroke has high rates of mortality (31% versus 16.7%) and disability (78% versus 48%) in the aged patient versus the younger one. 2 We think that warfarin could reduce the stroke risk in persons with AF and should be used independent of age, especially in the elderly with other associated risk factors. This may be an opportunity to improve the quality of life and care of our elderly patients.
Response:
In their retrospective study of acute stroke patient admissions, Marti and Anton focused on the very elderly, Ͼ90 years of age. The majority (64%) exhibited atrial fibrillation (AF), but none were under warfarin before the stroke. The death rate was high in these very old patients, especially in AF patients. Physicians are usually reluctant to apply recommendations in elderly with AF because they fear hemorrhagic side effects of long-term use of warfarin. 1 Although the risk of life-threatening hemorrhage is higher in elderly under anticoagulation, there is an alternative higher risk of ischemic stroke in AF patients Ͼ80 to 85 years, which overwhelms the former. 2 Warfarin has been shown to reduce stroke rates by 68%. 2 Therefore, as a rule, warfarin is mandatory in at-risk patients with AF, whatever their age. Neurologists have to make a special effort because they underuse anticoagulation compared with cardiologists. 3 It was suggested in elderly AF patients to lower intensity of anticoagulation (international normalized ratio [INR], 1.5 to 1.9) in view of the balance between prevention of thromboembolism and the adverse effect by warfarin (ie, bleeding). 4 However, in a recent retrospective study, INRs Ͻ2.0 were not associated with lower risk for intracranial hemorrhage compared with INRs between 2.0 and 3.0. 5 Ximelagatran, a new oral direct thrombin inhibitor, might provide a more physician-and patient-friendly method of stroke prophylaxis, especially in the elderly. 1 We must keep in mind that because of the rapidly aging population, physicians are challenged with more and more older patients with AF, for whom optimal prevention of stroke is crucial. 
Embolus Detection and Differentiation Using Multifrequency Transcranial Doppler
In our articles in Stroke in August 2002, 1,2 we presented our findings using the first multifrequency transcranial Doppler (TCD) to detect and differentiate cerebral emboli. Since this time, we have had considerable experience using multifrequency TCD in medical patients during invasive cardiovascular investigations and perioperatively during heart surgery. We found that results are most reliable for embolus differentiation when the Doppler signal enhancement, ie embolus-blood-ratio (EBR), is Ͼ28 dB/ms (ie, a Doppler power increase Ͼ7 dB, which lasts Ͼ4 ms) simultaneously in 2.0-MHz and 2.5-MHz channels. The lower dEBR limit for the classification of solid microemboli 2 should also not be horizontal but have a slight slope of yϭϪ0.1xϪ0.12 dB, where yϭdEBR and xϭ2.0 MHz EBR.
Embolus detection and differentiation is also very difficult when there are bursts of gaseous or solid emboli, when several emboli may enter the sample volume at the same time. Ultrasound contrast bubbles may make detection and differentiation difficult because of changes in the background signal or resonance effects of single contrast bubbles. 
David Russell, MD

Postcarotid Endarterectomy Hyperfusion or Reperfusion Syndrome
To the Editor: I read with great interest the study by Karapanayiotides et al. 1 This study highlighted several important features of the hyperperfusion syndrome and raises several questions.
It is not entirely surprising that the middle cerebral artery mean flow velocities do not reliably predict the occurrence of the hyperperfusion syndrome. The relationship between velocity and volumetric flow is complex and not always predictable. As suggested, it is likely that volumetric flow may contribute to microvascular trauma. Furthermore, the relationship between the release of free radicals and metabolic products after reperfusion and their contribution to intracerebral endothelial dysfunction has not been studied adequately in this setting.
In addition, did the authors find any correlation between the degree of contralateral internal carotid artery stenosis and the risk of hyperperfusion syndrome? It would be interesting to determine whether the precarotid endarterectomy relative interhemispheric difference of cerebral blood flow predicted the hyperperfusion syndrome postcarotid endarterectomy.
Finally, in light of this complex process, the suggestion that "reperfusion syndrome" rather than "hyperperfusion syndrome" be used to describe this process may be appropriate. 
Robert S. Dieter, MD, RVT
Response:
We deeply appreciate Dr Dieter's interest in our study. We agree with Dr Dieter's statement that the relationship between velocity and volumetric flow is complex. However, in the case of patients undergoing carotid endarterectomy, this complexity has been elegantly demonstrated only once before. 1 The authors concluded that for all pairs of measurement at a regional cerebral blood flow (CBF) of Ͼ20 mL/100 g per minute, there was little relationship between regional CBF and middle cerebral artery (MCA) mean flow velocity. Furthermore, postischemic hyperemia after the release of clamping was evident in measurements of mean velocity but not of regional CBF. Accordingly, in a case report studied with single-photon emission computed tomography, 2 equally increased MCA mean flow velocities were found in the hyperperfused and the contralateral hemisphere. We believe that our data offer the stimulus for further research on the relationship between transcranial Doppler ultrasonography and other techniques of CBF measurement.
We also agree that the hemodynamic modifications observed after endarterectomy are coupled tightly to delicate neuroeffector mechanisms triggered after reperfusion, 3 which amply merits investigation.
In our study, we cannot document any relationship between the degree of contralateral internal carotid artery stenosis and the risk of hyperperfusion syndrome because of the small number of patients. Among the patients who developed symptoms of hyperperfusion, only 1 had bilateral internal carotid artery stenosis Ͼ90%. This patient had initially undergone an uncomplicated right endarterectomy, and 1 week later, she underwent a left endarterectomy that was followed 5 days later by a massive intracerebral hemorrhage. This was the only patient who had abnormally increased MCA mean flow velocities ipsilateral to the endarterectomy site (and interestingly, contralateral to it), but most unfortunately, this patient was not studied with perfusionor diffusion-weighted MRI. We also compared the mean relative interhemispheric difference of the MCA mean flow velocity between patients who developed hyperperfusion syndrome and those who did not and found no difference (27Ϯ11 versus 24Ϯ10; Pϭ0.3; Mann-Whitney test). However, this analysis has limited value because of the small number of patients and the aforementioned limitations of transcranial Doppler ultrasonography to assess interhemispheric CBF differences over the cortical convexity.
